Pravin Patil — investor profile photo

Pravin Patil

Managing Partner, PranaTech Ventures · Deep Tech VC · Cybersecurity · Vertical AI · Founder → Exit to The Carlyle Group . NJ Innovate 100

📍 United States🔄 Updated November 2026💼 2 investments📅 3 years investing🗓 Last invested Jan 2023
VC🌍 United States
2
Total investments
0
Early stage
0
Mid stage
0
Late stage
3y
Years active

Portfolio

0 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
No investments found
Experience · 6 entries
All (6)
Investments (2)
Founder (2)
2025
2023
Venture Partner
Jan 2023
Pentathlon Ventures is an early stage VC Fund focusing on the thriving B2B SaaS space in the vibrant Indian startup ecosystem, leveraging the innovation, talent and cost advantage to build global products. We work with early-stage technology companies to scale their business by providing Expertise, Ecosystem & Capital. Our mission is to empower ambitious tech entrepreneurs at every stage of their journey. As a founder-led VC firm, we bridge the gap between Angel and Series A+ rounds, supporting innovative startups to grow and succeed. The GP team comprises entrepreneurs turned fund managers with a proven record of building successful companies both in India and the US. They are passionate about actively mentoring and coaching startups in their journey to scale their ventures. Their insights and guidance are based on first-hand experience of establishing and scaling multiple entrepreneurial companies. If you’re excited about the possibility of partnering with us, we’d love to hear from you !
Investor
2023
As experts in cytokine biology, our clinical stage pipeline comprises five cytokine-derived therapeutic candidates, with our lead proprietary compound, SON-1010, in Phase 1 development. Closely following are SON-080, in Phase 1b/2a development, and three other candidates undergoing preclinical study. Sonnet’s proprietary FHAB™ (Fully Human Albumin Binding) technology enables the development of innovative targeted biologic drugs with enhanced single- or bi-specific mechanisms. The FHAB™ platform utilizes a fully human single chain antibody fragment (scFv) that binds to and “hitchhikes” on human serum albumin (HSA) for transport to target tissues. Our internal focus is immune oncology, however, we believe our technology is suited for drug development across the spectrum of human disease. Sonnet’s FHAB construct attaches to albumin in the bloodstream, which significantly enhances the pharmacokinetics of the active drug substance. It also naturally accumulates at inflammation sites, including tumors, thereby potentiating delivery to target tissues. Our platform has demonstrated a tenfold increase in half-life and a greater-than-thirtyfold increase in efficacy as compared to recombinant interleukins without FHAB in preclinical studies. We believe the versatile platform can generate a large immune oncology pipeline, including combinations with a variety of biologic drugs. The Sonnet platform is differentiated in that FHAB utilizes a fully human sequence with a human glycosylation profile that can be manufactured using a standard CHO process. (NASDAQ: SONN)
Investor and Advisor
2023
At ImageProVision Technology Pvt. Ltd., we focus on processing and detailed analysis of images, along with the development of image processing applications. Our products cater to a wide range of industries including pharmaceuticals, medical sciences, life sciences, agriculture, defence etc. We also render precision services toward video processing, 3D imaging and industrial vision processing. Our product for pharmaceutical industry "ipvPClass"​ a microscopy Particle Size Analyser & Classifier is very popular. We have a number of reputed clients such as Dr. Reddys, Lupin, Glenmark, Zydus Cadila, Amneal etc. We are also having an expert team in Medical Imaging technology.
2013
CEO / Co-Founder
Oct 2013
In 2022, Kapstone was acquired by iC Consult Group. Visit our website: www.ic-consult.com *** Kapstone LLC is a leading provider of advanced cyber security solutions and offering end-to-end security consulting, implementation, and training services. Kapstone has developed comprehensive Cyber Security toolkit based on our prior decades of experience implementing CJIS 5.x, HIPAA, NIST 800-53 driven Cyber Security Program. Kapstone helps you understand regulatory mandates, Operational requirements and best practices, assess your current situation, and help you develop an effective action plan for Cyber Security initiative. Beyond compliance, Kapstone’s goal is to help the customer achieve truly effective security through a best-practices approach to cybersecurity risk management. Kapstone LLC developed next-generation threat intelligence, entitlement, and data access governance solutions. Kapstone’s threat intelligence platform for enterprise applications provides continuous control and compliance monitoring. Kapstone’s data access governance platform helps control unstructured data on the on-premises & cloud and determine access rights to it. Kapstone’s data access governance platform provides out of the box integrations with OneDrive, Sharepoint, BOX and DLP solution.
Show all 6 entries ↓
Investor lists
Lists that match Pravin's portfolio